← Back to Search

Palliative Care for Liver Transplant Candidates (ASPECT-Pilot Trial)

N/A
Waitlist Available
Led By Myrick C Shinall, MD, PhD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
adult patients (age 18 years or greater) undergoing evaluation for liver transplantation at Vanderbilt University Medical Center
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights

ASPECT-Pilot Trial Summary

This trial is testing whether a specialist palliative care intervention could help patients who are being evaluated for a liver transplant.

Who is the study for?
This trial is for adults over 18 being evaluated for liver transplantation at Vanderbilt University Medical Center. Participants must live in Tennessee, speak English fluently, have a telephone, and not be prisoners or deaf. They should not already be receiving specialist palliative care.Check my eligibility
What is being tested?
The study is testing the addition of specialist palliative care consultations to the standard process of evaluating patients for liver transplants. It aims to gather information to design a larger future trial on this approach.See study design
What are the potential side effects?
Since this trial involves consultations rather than medications or invasive procedures, traditional side effects are not expected. However, emotional or psychological distress from discussions about serious illness may occur.

ASPECT-Pilot Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am an adult being evaluated for a liver transplant at Vanderbilt.

ASPECT-Pilot Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of Intervention
Appropriateness of Intervention

ASPECT-Pilot Trial Design

1Treatment groups
Experimental Treatment
Group I: Specialist Palliative CareExperimental Treatment1 Intervention
All patients will be assigned to receive the intervention, consisting of two outpatient palliative care visits at Vanderbilt University Medical Center (VUMC).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Palliative Care Consultation
2012
N/A
~300

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
850 Previous Clinical Trials
669,112 Total Patients Enrolled
Myrick C Shinall, MD, PhDPrincipal InvestigatorAssistant Professor

Media Library

Palliative Care Consultation Clinical Trial Eligibility Overview. Trial Name: NCT05147935 — N/A
Liver Disease Research Study Groups: Specialist Palliative Care
Liver Disease Clinical Trial 2023: Palliative Care Consultation Highlights & Side Effects. Trial Name: NCT05147935 — N/A
Palliative Care Consultation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05147935 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current vacancies in this research program?

"As confirmed by clinicaltrials.gov, this particular research endeavour is not presently seeking participants. First posted on March 31st 2022 and subsequently updated four days later, the trial does not have any openings at present; though there are 273 other trials with open recruitment spots currently available."

Answered by AI
~5 spots leftby Mar 2025